EUVIMEDDescoperă EUVIMED
Open access · CC BY-NC-ND 4.0

Type II Diabetes Mellitus Causes Extracellular Matrix Alterations in the Posterior Cornea That Increase Graft Thickness and Rigidity

Kenten D Kingsbury, Jessica M Skeie, Krista Cosert, Gregory A Schmidt, Benjamin T Aldrich, Christopher S Sales, Julia Weller, Friedrich Kruse, Sara M Thomasy, Ursula Schlötzer-Schrehardt, Mark A Greiner

Investigative Opthalmology & Visual Science · 2023

DOI: 10.1167/iovs.64.7.26 ↗

At a glance

Journal article in Investigative Opthalmology & Visual Science, 2023. Written by Kenten D Kingsbury and 10 co-authors. Institution: Department of Ophthalmology and Visual Sciences, Carver College of Medicine, University of Iowa, Iowa City, Iowa, United States. Major MEDLINE topics: Diabetes Mellitus, Type 2, Descemet Stripping Endothelial Keratoplasty, Hyperglycemia. Cited 15 times so far (Crossref); 30 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: NEI NIH HHS.

RezumatSubjectsDate bibliograficeCiteRelated studies

Abstract (original language)

Purpose

There is a pressing need to investigate the impact of type II diabetes mellitus on the posterior cornea in donor tissues given its increasing prevalence and potential impact on endothelial keratoplasty surgical outcomes.

Methods

Immortalized human cultured corneal endothelial cells (CECs; HCEC-B4G12) were grown in hyperglycemic media for 2 weeks. Extracellular matrix (ECM) adhesive glycoprotein expression and advanced glycation end products (AGEs) in cultured cells and corneoscleral donor tissues, as well as the elastic modulus for the Descemet membrane (DMs) and CECs of diabetic and nondiabetic donor corneas, were measured.

Results

In CEC cultures, increasing hyperglycemia resulted in increased transforming growth factor beta-induced (TGFBI) protein expression and colocalization with AGEs in the ECM. In donor corneas, the thicknesses of the DM and the interfacial matrix (IFM) between the DM and stroma both increased from 8.42 ± 1.35 µm and 0.504 ± 0.13 µm in normal corneas, respectively, to 11.13 ± 2.91 µm (DM) and 0.681 ± 0.24 µm (IFM) in non-advanced diabetes (P = 0.013 and P = 0.075, respectively) and 11.31 ± 1.76 µm (DM) and 0.744 ± 0.18 µm (IFM) in advanced diabetes (AD; P = 0.0002 and P = 0.003, respectively). Immunofluorescence in AD tissues versus controls showed increased AGEs (P < 0.001) and markedly increased labeling intensity for adhesive glycoproteins, including TGFBI, that colocalized with AGEs. The elastic modulus significantly increased between AD and control tissues for the DMs (P < 0.0001) and CECs (P < 0.0001).

Conclusions

Diabetes and hyperglycemia alter human CEC ECM structure and composition, likely contributing to previously documented complications of endothelial keratoplasty using diabetic donor tissue, including tearing during graft preparation and reduced graft survival. AGE accumulation in the DM and IFM may be a useful biomarker for determining diabetic impact on posterior corneal tissue.

Subjects

MeSH terms (MEDLINE)

Diabetes Mellitus, Type 2Descemet Stripping Endothelial KeratoplastyHyperglycemiaHumansDescemet MembraneEndothelial CellsCorneaExtracellular MatrixGlycation End Products, AdvancedTissue DonorsEndothelium, Corneal

Substances

Glycation End Products, Advanced

Authors and institutions

  • Department of Ophthalmology and Visual Sciences, Carver College of Medicine, University of Iowa, Iowa City, Iowa, United States.
  • Iowa Lions Eye Bank, Coralville, Iowa, United States.
  • Department of Surgical & Radiological Sciences, School of Veterinary Medicine, University of California, Davis, Davis, California, United States.
  • Department of Ophthalmology & Vision Science, School of Medicine, University of California, Davis, Davis, California, United States.
  • Department of Ophthalmology, Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany.

Funding

  • NEI NIH HHS

Cite

APA

Kingsbury, K. D., Skeie, J. M., Cosert, K., Schmidt, G. A., Aldrich, B. T., Sales, C. S., Weller, J., Kruse, F., Thomasy, S. M., Schlötzer-Schrehardt, U., & Greiner, M. A. (2023). Type II Diabetes Mellitus Causes Extracellular Matrix Alterations in the Posterior Cornea That Increase Graft Thickness and Rigidity. Investigative Opthalmology & Visual Science. https://doi.org/10.1167/iovs.64.7.26

Vancouver

Kingsbury KD, Skeie JM, Cosert K, Schmidt GA, Aldrich BT, Sales CS, et al. Type II Diabetes Mellitus Causes Extracellular Matrix Alterations in the Posterior Cornea That Increase Graft Thickness and Rigidity. Investigative Opthalmology & Visual Science. 2023. doi:10.1167/iovs.64.7.26

BibTeX
@article{Kingsbury2023,
  author = {Kingsbury, Kenten D and Skeie, Jessica M and Cosert, Krista and Schmidt, Gregory A and Aldrich, Benjamin T and Sales, Christopher S and Weller, Julia and Kruse, Friedrich and Thomasy, Sara M and Schlötzer-Schrehardt, Ursula and Greiner, Mark A},
  title = {Type II Diabetes Mellitus Causes Extracellular Matrix Alterations in the Posterior Cornea That Increase Graft Thickness and Rigidity},
  journal = {Investigative Opthalmology & Visual Science},
  year = {2023},
  doi = {10.1167/iovs.64.7.26}
}
Start for free →